Chinese Medical Journal (Feb 2025)
Potential utility of albumin–bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors
- Lianxi Song,
- Qinqin Xu,
- Ting Zhong,
- Wenhuan Guo,
- Shaoding Lin,
- Wenjuan Jiang,
- Zhan Wang,
- Li Deng,
- Zhe Huang,
- Haoyue Qin,
- Huan Yan,
- Xing Zhang,
- Fan Tong,
- Ruiguang Zhang,
- Zhaoyi Liu,
- Lin Zhang,
- Xiaorong Dong,
- Ting Li,
- Chao Fang,
- Xue Chen,
- Jun Deng,
- Jing Wang,
- Nong Yang,
- Liang Zeng,
- Yongchang Zhang,
- Peifang Wei
Affiliations
- Lianxi Song
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Qinqin Xu
- 4 Department of Medical Oncology, Qinghai Provincial People’s Hospital, Xining, Qinghai 810000, China
- Ting Zhong
- 3 Department of Medical Oncology, Yiyang Central Hospital, Yiyang, Hunan 413000, China
- Wenhuan Guo
- 5 Department of Pathology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 20025, China
- Shaoding Lin
- 6 Department of Medical Oncology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua, Hunan 418000, China
- Wenjuan Jiang
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Zhan Wang
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Li Deng
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Zhe Huang
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Haoyue Qin
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Huan Yan
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Xing Zhang
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Fan Tong
- 6 Department of Medical Oncology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua, Hunan 418000, China
- Ruiguang Zhang
- 7 Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China
- Zhaoyi Liu
- 8 Department of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan 410008, China
- Lin Zhang
- 9 Department of Radiotherapy, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan 410008, China
- Xiaorong Dong
- 7 Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China
- Ting Li
- 10 Department of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan 410008, China
- Chao Fang
- 11 Early Clinical Trial Center, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Xue Chen
- 11 Early Clinical Trial Center, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Jun Deng
- 11 Early Clinical Trial Center, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Jing Wang
- 11 Early Clinical Trial Center, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Nong Yang
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Liang Zeng
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Yongchang Zhang
- 1 Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
- Peifang Wei
- DOI
- https://doi.org/10.1097/CM9.0000000000003385
- Journal volume & issue
-
Vol. 138,
no. 4
pp. 478 – 480
Abstract
No abstracts available.
